| Management number | 231900977 | Release Date | 2026/06/18 | List Price | US$27.32 | Model Number | 231900977 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
This book discusses why specific diseases are being targeted for cell-based retinal therapy, what evidence exists that justifies optimism for this approach, and what challenges must be managed in order to bring this technology from the laboratory into routine clinical practice. There are a number of unanswered questions (e.g., surgical approach to cell delivery, management of immune response, optimum cell type to transplant) that very likely are not going to be answered until human trials are undertaken, but there is a certain amount of “de-risking” that can be done with preclinical experimentation. This book is essential reading for scientists, clinicians, and advanced students in stem cell research, cell biology, and ophthalmology. Read more
| ASIN | B07PHN75DR |
|---|---|
| XRay | Not Enabled |
| ISBN13 | 978-3030052225 |
| Edition | 1st ed. 2019 |
| Language | English |
| File size | 10.6 MB |
| Page Flip | Enabled |
| Publisher | Humana |
| Word Wise | Not Enabled |
| Print length | 553 pages |
| Accessibility | Learn more |
| Screen Reader | Supported |
| Part of series | Stem Cell Biology and Regenerative Medicine |
| Publication date | March 1, 2019 |
| Enhanced typesetting | Enabled |
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form